0521779407-08 CUNY1086/Karliner 0 521 77940 7 June 13, 2007 7:47
Glomerular Diseases 633
specific therapy
■Minimal Change Disease: Prednisone for 2 months and then
taper. Second line therapies cyclosporine, cyclophosphamide, other
immunosuppressives.
■Focal glomerulosclerosis: Primary-Idiopathic Disease- Only treat
patients with >3 g proteinuria/Day; Prednisone at a high starting
dose and then taper for at least 6 months. Prednisone failures Rx
with cyclosporine for 6 mo; Alternate therapy cyclophosphamide or
other immunosuppression.
■Membranous Nephropathy: Only treat patients at high risk for renal
failure (heavy proteinuria, increased age, male sex, elevated plasma
creatinine). Possible treatments: 1) monthly steroids alternating with
monthly cyclophosphamide or chlorambucil for 6 mo. 2) 6 months
QOD prednisone in tapering dose. 3) cyclosporine
■MPGN: None proven
■IgA Nephropathy: Control of HBP with ACE inhibitor or ARB; Low
protein diet; Even if BP normal use ACE inhibitor or ARB to decrease
progressive disease. In higher risk patients (males, heavy proteinuria,
high creatinine, etc) may try alternate day steroids for 6 mo, fish oils,
other immunosuppressives
■Poststreptococcal glomerulonephritis: Antibiotics to treat acute
infection; No specific therapy; in most cases renal failure and sxs
resolve spontaneously
■Rapidly Progressive GN
■Anti-GBM disease – steroids, cyclophosphamide and plasmaphere-
sis (to remove anti-GBM antibody)
■ANCA+disease – cyclophosphamide and prednisone
■Immune complex RPGN – treat basic disease (SLE: cyclophos-
phamide and steroids, post-strep: no immunosuppressive)
■Asymptomatic urinary findings: No specific therapy
follow-up
■Follow for remission of proteinuria
■Minimal Change Disease: Relapses in many patients – retreat with
steroids for first and second relapse; Frequent relapses or steroid
resistant use cyclosporine or cyclophosphamide.
■Asymptomatic urinary findings: Biopsy if systemic sx or decrease Ccr
or increase proteinuria >1 g/day
complications and prognosis
■In general persistent heavier proteinuria predicts worse outcome.